Lista de obras -

1047Use of electronic data to identify new zoster cases for a vaccine effectiveness study.

artículo científico publicado en 2014

1078Risk Factors Associated with Developing Fever Following First Dose Measles-Containing Vaccines.

artículo científico publicado en 2014

1105Chronic Kidney Disease and Invasive Pneumococcal Disease in Adults

1578Clinical Features, Vaccine Status and S. Pneumoniae Serotypes among HIV-positive and HIV-negative Individuals Diagnosed with Invasive Pneumococcal Disease.

artículo científico publicado en 2014

2461. Safety of Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid-Conjugate Vaccine in Adolescents

597Increase in IPD incidence in Adults in 2013-2014 after 2 consecutive years of decline following introduction of 13-valent pneumococcal conjugate vaccine (PCV13).

artículo científico publicado en 2014

A Phase III Evaluation of Immunogenicity and Safety of Two Trivalent Inactivated Seasonal Influenza Vaccines in US Children

article

A postlicensure evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 24-59 months of age.

artículo científico publicado en 2013

A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18-49 years of age.

artículo científico publicado en 2012

A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age.

artículo científico publicado en 2012

Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season

artículo científico publicado en 2014

Acute Demyelinating Events Following Vaccines: A Case-Centered Analysis.

artículo científico publicado en 2016

Algorithm to assess causality after individual adverse events following immunizations

artículo científico publicado en 2012

Antibody persistence after primary and booster doses of a quadrivalent meningococcal conjugate vaccine in adolescents

scientific article published on 01 November 2014

Antibody persistence and booster response of a quadrivalent meningococcal conjugate vaccine in adolescents

artículo científico publicado en 2014

Assessing the safety of influenza vaccination in specific populations: children and the elderly

artículo científico publicado en 2012

Asthma exacerbations among asthmatic children receiving live attenuated versus inactivated influenza vaccines.

artículo científico publicado en 2017

Biologically plausible and evidence-based risk intervals in immunization safety research

artículo científico

Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009-2010.

artículo científico publicado en 2017

C-B5-02: H1N1 Vaccine Safety Monitoring in the Vaccine Safety Datalink Project: New Challenges and Useful Lessons.

artículo científico publicado en 2010

Case-centered Analysis of Optic Neuritis After Vaccines

artículo científico publicado en 2016

Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients

artículo científico publicado en 2008

Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).

artículo científico

Cervical intraepithelial neoplasia grade 3 and adenocarcinoma in situ: comparison of ICD-9 codes and pathology results--Kaiser Permanente, United States, 2000-2005.

artículo científico publicado en 2013

Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers

artículo científico

Corrigendum to "Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years" [Vaccine 35 (2017) 1254-1258]

artículo científico publicado en 2017

Developing the next generation of vaccinologists

artículo científico publicado en 2011

Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children

artículo científico publicado en 2013

Effect of influenza vaccination on hospitalizations in persons aged 50 years and older ⬇️

artículo científico publicado el 9 de septiembre de 2010

Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis

artículo científico publicado en 2017

Effectiveness of pertussis vaccines for adolescents and adults: case-control study

artículo científico publicado en 2013

Epidemiologic and clinical features of Bell's palsy among children in Northern California

artículo científico publicado en 2012

Estimated rates of influenza-associated outpatient visits during 2001-2010 in six US integrated health care delivery organizations

artículo científico publicado en 2017

Evaluation of immunization rates and safety among children with inborn errors of metabolism.

artículo científico publicado en 2011

Evidence of bias in studies of influenza vaccine effectiveness in elderly patients.

artículo científico publicado en 2010

Five-year Antibody Persistence and Booster Response to a Single Dose of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Adolescents and Young Adults: An Open, Randomized Trial

artículo científico publicado en 2015

Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study

artículo científico publicado en 2009

Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic.

artículo científico publicado en 2013

Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011.

artículo científico publicado en 2013

Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data

artículo científico publicado en 2011

H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project

artículo científico publicado en 2011

Hospital-level rates of fluoroquinolone use and the risk of hospital-acquired infection with ciprofloxacin-nonsusceptible Pseudomonas aeruginosa

artículo científico

Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS.

artículo científico publicado en 2013

Immunization and Bell's palsy in children: a case-centered analysis

artículo científico publicado en 2012

Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine Coadministered with a Quadrivalent Influenza Vaccine in Adults 50 Years and Older Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine

artículo científico publicado en 2015

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal ACWY Tetanus Toxoid Conjugate Vaccine in Healthy Adolescents and Young Adults 10 to 25 Years of Age ⬇️

artículo científico publicado el 1 de marzo de 2011

Impact of an electronic medical record reminder on hepatitis B vaccine initiation and completion rates among insured adults with diabetes mellitus

artículo científico publicado en 2018

Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use

artículo científico publicado en 2020

Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults

scientific article published on 01 April 2006

Impact of vaccination on the epidemiology of varicella

artículo científico publicado en 2015

Impact of vaccination on the epidemiology of varicella: 1995-2009.

artículo científico publicado en 2014

Incidence of Herpes Zoster Among Children: 2003-2014

scientific article published on 10 June 2019

Influenza vaccination and mortality: differentiating vaccine effects from bias

artículo científico publicado en 2009

Injection site and risk of medically attended local reactions to acellular pertussis vaccine

artículo científico publicado en 2011

Kaiser Permanente Northern California pregnancy database: Description and proof of concept study

artículo científico

Kaiser Permanente Vaccine Study Center: Highlights of 2009-2012.

artículo científico publicado en 2013

Lack of association of Guillain-Barré syndrome with vaccinations

artículo científico publicado en 2013

Live attenuated influenza vaccine use and safety in children and adults with asthma.

artículo científico publicado en 2017

Live vaccine use and safety in DiGeorge syndrome

artículo científico publicado en 2014

Long term risk of developing type 1 diabetes after HPV vaccination in males and females

artículo científico publicado en 2019

Long-Term Effectiveness of the Live Zoster Vaccine in Preventing Shingles: A Cohort Study

artículo científico publicado en 2018

Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study

artículo científico publicado en 2013

Measles-containing vaccines and febrile seizures in children age 4 to 6 years

artículo científico publicado en 2012

Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures

artículo científico publicado en 2010

Monitoring vaccine safety using the Vaccine Safety Datalink: utilizing immunization registries for pandemic influenza

artículo científico publicado en 2011

Mortality Rates and Cause-of-Death Patterns in a Vaccinated Population

article by Natalie L McCarthy et al published July 2013 in American Journal of Preventive Medicine

Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project.

artículo científico publicado en 2009

No association between influenza vaccination during pregnancy and adverse birth outcomes

artículo científico publicado en 2017

Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010.

artículo científico publicado en 2012

Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study

artículo científico publicado en 2009

Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo®) or Menactra® among healthy adolescents

artículo científico publicado en 2010

Persistence of the immune response after MenACWY-CRM vaccination and response to a booster dose, in adolescents, children and infants

artículo científico publicado en 2016

Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents

artículo científico

Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013-2014 and 2014-2015 seasons

artículo científico publicado en 2016

Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine.

scientific article published on 07 July 2016

Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente

artículo científico publicado en 2004

Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children

artículo científico publicado en 2013

Prevalence of HPV types in cervical specimens from an integrated healthcare delivery system: baseline assessment to measure HPV vaccine impact

artículo científico publicado en 2013

Quadrivalent meningococcal vaccination of adults: phase III comparison of an investigational conjugate vaccine, MenACWY-CRM, with the licensed vaccine, Menactra

artículo científico publicado en 2009

Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies

artículo científico publicado en 2009

Recurrent Guillain-Barre syndrome following vaccination

scientific article published on 19 January 2012

Risk factors and familial clustering for fever 7-10days after the first dose of measles vaccines

artículo científico publicado en 2017

Risk of Herpes Zoster and Disseminated Varicella Zoster in Patients Taking Immunosuppressant Drugs at the Time of Zoster Vaccination

artículo científico publicado en 2015

Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010.

artículo científico publicado en 2012

Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010.

artículo científico publicado en 2012

Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: A Vaccine Safety Datalink study

artículo científico publicado en 2009

Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age.

artículo científico publicado en 2011

Risk of underlying chronic medical conditions for invasive pneumococcal disease in adults

artículo científico

Routinely vaccinating adolescents against meningococcus: targeting transmission & disease

artículo científico publicado en 2015

Safety of Zostavax™--a cohort study in a managed care organization

artículo científico publicado en 2012

Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population

artículo científico publicado en 2012

Safety of measles-containing vaccines in 1-year-old children

artículo científico publicado en 2015

Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years.

artículo científico publicado en 2017

Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI).

artículo científico publicado en 2009

Sudden-Onset Sensorineural Hearing Loss after Immunization: A Case-Centered Analysis.

artículo científico publicado en 2016

The Vaccine Safety Datalink: a model for monitoring immunization safety

artículo científico publicado en 2011

The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety.

artículo científico publicado en 2014

The risk of immune thrombocytopenic purpura after vaccination in children and adolescents

artículo científico publicado en 2012

Treatment with monoclonal antibodies against Clostridium difficile toxins

artículo científico publicado en 2010

Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network

artículo científico publicado en 2011

Vaccination Site and Risk of Local Reactions in Children 1 Through 6 Years of Age

artículo científico publicado en 2013

Vaccination and 30-Day Mortality Risk in Children, Adolescents, and Young Adults.

artículo científico publicado en 2016

Varicella vaccination and ischemic stroke in children: is there an association?

artículo científico

Waning Tdap Effectiveness in Adolescents

artículo científico

Waning protection after fifth dose of acellular pertussis vaccine in children

artículo científico publicado en 2012

Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccine

artículo científico

Lista de obras de

1047Use of electronic data to identify new zoster cases for a vaccine effectiveness study.

1078Risk Factors Associated with Developing Fever Following First Dose Measles-Containing Vaccines.

1105Chronic Kidney Disease and Invasive Pneumococcal Disease in Adults

1578Clinical Features, Vaccine Status and S. Pneumoniae Serotypes among HIV-positive and HIV-negative Individuals Diagnosed with Invasive Pneumococcal Disease.

2461. Safety of Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid-Conjugate Vaccine in Adolescents

597Increase in IPD incidence in Adults in 2013-2014 after 2 consecutive years of decline following introduction of 13-valent pneumococcal conjugate vaccine (PCV13).

A Phase III Evaluation of Immunogenicity and Safety of Two Trivalent Inactivated Seasonal Influenza Vaccines in US Children

A postlicensure evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 24-59 months of age.

A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18-49 years of age.

A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age.

Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season

Acute Demyelinating Events Following Vaccines: A Case-Centered Analysis.

Algorithm to assess causality after individual adverse events following immunizations

Antibody persistence after primary and booster doses of a quadrivalent meningococcal conjugate vaccine in adolescents

Antibody persistence and booster response of a quadrivalent meningococcal conjugate vaccine in adolescents

Assessing the safety of influenza vaccination in specific populations: children and the elderly

Asthma exacerbations among asthmatic children receiving live attenuated versus inactivated influenza vaccines.

Biologically plausible and evidence-based risk intervals in immunization safety research

Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009-2010.

C-B5-02: H1N1 Vaccine Safety Monitoring in the Vaccine Safety Datalink Project: New Challenges and Useful Lessons.

Case-centered Analysis of Optic Neuritis After Vaccines

Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients

Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).

Cervical intraepithelial neoplasia grade 3 and adenocarcinoma in situ: comparison of ICD-9 codes and pathology results--Kaiser Permanente, United States, 2000-2005.

Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers

Corrigendum to "Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years" [Vaccine 35 (2017) 1254-1258]

Developing the next generation of vaccinologists

Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children

Effect of influenza vaccination on hospitalizations in persons aged 50 years and older ⬇️

Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis

Effectiveness of pertussis vaccines for adolescents and adults: case-control study

Epidemiologic and clinical features of Bell's palsy among children in Northern California

Estimated rates of influenza-associated outpatient visits during 2001-2010 in six US integrated health care delivery organizations

Evaluation of immunization rates and safety among children with inborn errors of metabolism.

Evidence of bias in studies of influenza vaccine effectiveness in elderly patients.

Five-year Antibody Persistence and Booster Response to a Single Dose of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Adolescents and Young Adults: An Open, Randomized Trial

Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study

Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic.

Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011.

Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data

H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project

Hospital-level rates of fluoroquinolone use and the risk of hospital-acquired infection with ciprofloxacin-nonsusceptible Pseudomonas aeruginosa

Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS.

Immunization and Bell's palsy in children: a case-centered analysis

Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine Coadministered with a Quadrivalent Influenza Vaccine in Adults 50 Years and Older Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal ACWY Tetanus Toxoid Conjugate Vaccine in Healthy Adolescents and Young Adults 10 to 25 Years of Age ⬇️

Impact of an electronic medical record reminder on hepatitis B vaccine initiation and completion rates among insured adults with diabetes mellitus

Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use

Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults

Impact of vaccination on the epidemiology of varicella

Impact of vaccination on the epidemiology of varicella: 1995-2009.

Incidence of Herpes Zoster Among Children: 2003-2014

Influenza vaccination and mortality: differentiating vaccine effects from bias

Injection site and risk of medically attended local reactions to acellular pertussis vaccine

Kaiser Permanente Northern California pregnancy database: Description and proof of concept study

Kaiser Permanente Vaccine Study Center: Highlights of 2009-2012.

Lack of association of Guillain-Barré syndrome with vaccinations

Live attenuated influenza vaccine use and safety in children and adults with asthma.

Live vaccine use and safety in DiGeorge syndrome

Long term risk of developing type 1 diabetes after HPV vaccination in males and females

Long-Term Effectiveness of the Live Zoster Vaccine in Preventing Shingles: A Cohort Study

Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study

Measles-containing vaccines and febrile seizures in children age 4 to 6 years

Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures

Monitoring vaccine safety using the Vaccine Safety Datalink: utilizing immunization registries for pandemic influenza

Mortality Rates and Cause-of-Death Patterns in a Vaccinated Population

Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project.

No association between influenza vaccination during pregnancy and adverse birth outcomes

Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010.

Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study

Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo®) or Menactra® among healthy adolescents

Persistence of the immune response after MenACWY-CRM vaccination and response to a booster dose, in adolescents, children and infants

Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents

Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013-2014 and 2014-2015 seasons

Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine.

Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente

Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children

Prevalence of HPV types in cervical specimens from an integrated healthcare delivery system: baseline assessment to measure HPV vaccine impact

Quadrivalent meningococcal vaccination of adults: phase III comparison of an investigational conjugate vaccine, MenACWY-CRM, with the licensed vaccine, Menactra